Named on 2 rounds in the feed, most often in Biotech.
Rounds from 2024-04-04 to 2026-11-11
ROUNDS
2
joined, none as lead
ROUNDS JOINED · USD
$168M
across 2 rounds
CO-INVESTORS
9
named beside it
Named on 2 rounds in the feed, most often in Biotech.
Rounds from 2024-04-04 to 2026-11-11
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Neurosterix A clinical-stage biotechnology company focused on transforming neuropsychiatric care through selective allosteric modulation | Series B Verified against 1 of 25 sources | $105M | 2026-11-11 | [ PART ] |
Neurosterix A clinical-stage biotechnology company focused on transforming neuropsychiatric care through selective allosteric modulation | Funding round Developing, 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $63M | 2024-04-04 | [ PART ] |